FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kai Eggers

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Myocardium

Co-author Network

Publications

TOP 3
Kai M Eggers; Bertil Lindahl; Per Venge; Lars Lind
Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.
Kai M Eggers; Per Venge; Lars Lind
Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
Kai M Eggers; Per Venge; Lars Lind
Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kai Eggers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kai M Eggers; Bertil Lindahl; Per Venge; Lars Lind
Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.
Journal of the American College of Cardiology 2013;61(18):1906-13.
2013: Kai M Eggers; Per Venge; Lars Lind
Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
Clinica chimica acta; international journal of clinical chemistry 2013;419():62-6.
2013: Kai M Eggers; Per Venge; Lars Lind
Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
The American journal of cardiology 2013;111(1):131-6.
2012: Kai M Eggers; Allan S Jaffe; Bodil Svennblad; Bertil Lindahl
A novel approach to cardiac troponins to improve the diagnostic work-up in chest pain patients.
Critical pathways in cardiology 2012;11(4):199-205.
2012: Kai M Eggers; Per Venge; Bertil Lindahl
High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain.
Clinica chimica acta; international journal of clinical chemistry 2012;413(13-14):1135-40.
2012: Tanja Savukoski; Per Venge; Saara Wittfooth; Noora Ristiniemi; Kai M Eggers; Janne Engblom; Emilia Engström; Bertil Lindahl; Kim Pettersson
Troponin-specific autoantibody interference in different cardiac troponin I assay configurations.
Clinical chemistry 2012;58(6):1040-8.
2012: Kai M Eggers; Per Venge
Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities.
Pathology 2012;44(2):129-38.
2012: Kai M Eggers; Tibor Kempf; Lars Lind; Johan Sundström; Lars Wallentin; Kai C Wollert; Agneta Siegbahn
Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects.
Scandinavian journal of clinical and laboratory investigation 2012;72(1):45-51.
2011: Kai M Eggers; Tomas Jernberg; Magnus Nygren; Per Venge; Bernt G Wikström
High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension.
Clinica chimica acta; international journal of clinical chemistry 2011;412(17-18):1582-8.
2011: Kai M Eggers; Allan S Jaffe; Per Venge; Bertil Lindahl
Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction.
Clinica chimica acta; international journal of clinical chemistry 2011;412(1-2):91-7.
2010: Bertil Lindahl; Per Venge; Kai M Eggers; Rolf Gedeborg; Noora Ristiniemi; Saara Wittfooth; Kim Pettersson
Autoantibodies to cardiac troponin in acute coronary syndromes.
Clinica chimica acta; international journal of clinical chemistry 2010;411(21-22):1793-8.
2010: Kai M Eggers; Tibor Kempf; Per Venge; Lars Wallentin; Kai C Wollert; Bertil Lindahl
Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
American heart journal 2010;160(1):88-94.
2010: Kai M Eggers; Paul W Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin; Stefan K James
ST2 and mortality in non-ST-segment elevation acute coronary syndrome.
American heart journal 2010;159(5):788-94.
2010: Kai M Eggers; Tibor Kempf; Bo Lagerqvist; Bertil Lindahl; Sylvia Olofsson; Franziska Jantzen; Timo Peter; Tim Allhoff; Agneta Siegbahn; Per Venge; Kai C Wollert; Lars Wallentin
Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
Circulation. Cardiovascular genetics 2010;3(1):88-96.
2010: Kai M Eggers; Mikael Dellborg; Nina Johnston; Jonas Oldgren; Eva Swahn; Per Venge; Bertil Lindahl
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
Clinical biochemistry 2010;43(3):240-5.
2009: Kai M Eggers; Bo Lagerqvist; Per Venge; Lars Wallentin; Bertil Lindahl
Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Journal of the American College of Cardiology 2009;54(4):357-64.
2009: Kai M Eggers; Lars Lind; Per Venge; Bertil Lindahl
Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?
The American journal of cardiology 2009;103(5):588-91.
2008: Kai M Eggers; Tibor Kempf; Tim Allhoff; Bertil Lindahl; Lars Wallentin; Kai C Wollert
Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain.
European heart journal 2008;29(19):2327-35.
2008: Kai M Eggers; Bo Lagerqvist; Jonas Oldgren; Per Venge; Lars Wallentin; Bertil Lindahl
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
American heart journal 2008;156(3):588-94.
2008: Kai M Eggers; Lars Lind; Håkan Ahlström; Tomas Bjerner; Charlotte Ebeling Barbier; Anders Larsson; Per Venge; Bertil Lindahl
Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.
European heart journal 2008;29(18):2252-8.
2008: Kai M Eggers; Mikael Dellborg; Jonas Oldgren; Eva Swahn; Per Venge; Bertil Lindahl
Risk prediction in chest pain patients by biochemical markers including estimates of renal function.
International journal of cardiology 2008;128(2):207-13.
2007: Kai M Eggers; Bo Lagerqvist; Per Venge; Lars Wallentin; Bertil Lindahl
Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
Circulation 2007;116(17):1907-14.
2007: Kai M Eggers; Johan Ellenius; Mikael Dellborg; Torgny Groth; Jonas Oldgren; Eva Swahn; Bertil Lindahl
Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patients.
International journal of cardiology 2007;114(3):366-74.
2005: Kai M Eggers; Jonas Oldgren; Anna Nordenskjöld; Bertil Lindahl
Combining different biochemical markers of myocardial ischemia does not improve risk stratification in chest pain patients compared to troponin I alone.
Coronary artery disease 2005;16(5):315-9.
2005: Kai M Eggers; Jonas Oldgren; Anna Nordenskjöld; Bertil Lindahl
Risk prediction in patients with chest pain: early assessment by the combination of troponin I results and electrocardiographic findings.
Coronary artery disease 2005;16(3):181-9.
2004: Kai M Eggers; Jonas Oldgren; Anna Nordenskjöld; Bertil Lindahl
Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction.
American heart journal 2004;148(4):574-81.